Voloridge Investment Management, LLC Bausch Health Companies Inc. Transaction History

Voloridge Investment Management, LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$7.77 - $10.61 $378,095 - $516,293	48,661 New	48,661 $516,000
Q3 2023 Nov 14, 2023	BUY	$7.69 - $9.71 $387,083 - $488,762	50,336 New	50,336 $413,000
Q1 2023 May 15, 2023	BUY	$6.28 - $9.85 $413,776 - $648,996	65,888 New	65,888 $533,000
Q3 2022 Nov 14, 2022	SELL	$4.58 - $9.21 $385,049 - $774,303	-84,072 Reduced 17.17%	405,564 $2.79 Million
Q2 2022 Aug 15, 2022	BUY	$7.06 - $23.63 $3.46 Million - $11.6 Million	489,636 New	489,636 $4.09 Million
Q1 2022 May 16, 2022	SELL	$21.6 - $27.79 $370,159 - $476,237	-17,137 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$23.0 - $29.01 $9.62 Million - $12.1 Million	-418,398 Reduced 96.07%	17,137 $473,000
Q3 2021 Nov 15, 2021	SELL	$25.04 - $30.06 $5.62 Million - $6.74 Million	-224,376 Reduced 34.0%	435,535 $12.1 Million
Q2 2021 Aug 16, 2021	BUY	$27.43 - $32.7 $2.47 Million - $2.95 Million	90,179 Added 15.83%	659,911 $19.3 Million
Q1 2021 May 17, 2021	BUY	$21.37 - $34.38 $12.2 Million - $19.6 Million	569,732 New	569,732 $18.1 Million
Q2 2020 Aug 14, 2020	SELL	$13.31 - $20.51 $448,826 - $691,617	-33,721 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$12.98 - $30.25 $1.79 Million - $4.18 Million	-138,112 Reduced 80.38%	33,721 $523,000
Q4 2019 Feb 14, 2020	BUY	$18.89 - $31.89 $3.25 Million - $5.48 Million	171,833 New	171,833 $5.14 Million
Q2 2019 Aug 14, 2019	SELL	$20.52 - $26.45 $1.35 Million - $1.74 Million	-65,874 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$20.23 - $26.29 $1.33 Million - $1.73 Million	65,874 New	65,874 $1.63 Million

255

254M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.7B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Voloridge Investment Management, LLC with notifications on news.